會議議程
Thursday, December 28, 2017| Time | Program |
| 0830-0900 | Registration |
| 0900-0930 | Welcome Remark |
| 0930-1020 |
Keynote Speaker
Is the scope of drug discovery in COPD changing?
Kazuhiro Ito, PhD
Honorary Principal Research Fellow, National Heart & Lung Institute, Imperial College, London, UK |
| 1020-1040 | Coffee Break |
| Section I: Chronic Lung Disease Moderator: Kang-Yun Lee, MD., PhD.
Director of Division of Pulmonary Medicine, Taipei Medical University |
|
| 1040-1110 | Prevention and management of COPD and asthma project in Vietnam
Phan Thu Phuong, MD.
Vice Director of Respiratory Center of Bach Mai hospital, Vietnam |
| 1110-1140 | The role of muscarinic antagonists on the pathophysiology of upper airway diseases
Wen-Te Liu, MD.
Assistant Professor, Division of Pulmonary Medicine, Shuang Ho Hospital, Taipei Medical University |
| 1140-1210 | Pulmonary Embolism: update in diagnosis and treatment
Le Thuong Vu, MD., PhD.
Lecturer and Clinical Instructor, Internal Medicine Department, Ho Chi Minh city University of Medicine and Pharmacy, Vietnam |
| 1210-1240 | Cigarette smoke-evoked oxidative stress promotes NF-κB activation and lung inflammation via E3 ligase ITCH-mediated TXNIP degradation
Chia-Ling Chen, PhD.
Assistant Research Fellow, Translational Research Center, Taipei Medical University |
| 1240-1330 | Lunch Break |
Section II: Environmental Lung disease Moderator: Tsan-Hon Liu, MD., PhD.
Vice Dean, College of Medicine, Taipei Medical University |
|
| 1330-1400 | Coal combustion emissions and lung cancer in Xuan Wei, China
Linwei Tian, PhD.
Associate Professor, School of Public Health, The University of Hong Kong |
| 1400-1430 | The effect of indoor air quality improvement on human health in the general population
Kai-Jen Chuang, PhD.
Professor, Division of Public Health, College of Medicine, Taipei Medical University |
| 1430-1500 | Personal exposure to PM2.5 (and their constituents) and airway inflammation in healthy adults
Kin Fai Ho, PhD.
Assistant Professor, Jockey Club School of Public Health and Primary Care, The Chinese University of Hong Kong |
| 1500-1530 | Investigation of sleep quality in shipyard workers by wearable device
Hsiao-Chi Chuang, PhD.
Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University |
| 1530-1600 | Coffee Break |
Section III: Respiratory Therapy Moderator: Bing-Chang Chen, PhD.
Director, School of Respiratory Therapy, College of Medicine, Taipei Medical University |
|
| 1600-1630 | Current status of respiratory therapy profession and education system in Taiwan
Mauo-Ying Bien, PhD.
Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University |
| 1630-1700 | Meaningful outcomes for the long term ventilated patient at home
Chan Yeow, MD.
Director, Home Ventilation and Respiratory Support Service, Tan Tock Seng Hospital, Singapore |
| 1700-1730 | Pulmonary eehabilitation in pateints with COPD
Shu-Chuan Ho, PhD.
Associate Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University |
| 1730-1800 | Inflammation induced airway hypersensitivity
Chun-Chun Hsu, PhD.
Assistant Professor, School of Respiratory Therapy, College of Medicine, Taipei Medical University |
| 1800-1830 | General Discussion |
Friday, December 29, 2017
| Time | Program |
| 0830-0900 | Registration |
| Section IV: Tuberculosis Moderator: Chen-Yuan Chiang, MD., PhD.
Associate Professor, Division of Pulmonary Medicine, Wan Fang Hospital, Taipei Medical University |
|
| 0900-0930 | Tuberculosis in Taiwan, the Impact of Population Aging
Chih-Hsin Lee, MD., PhD.
Assistant Professor, Division of Pulmonary Medicine, Wan Fang Hospital, Taipei Medical University |
| 0930-1000 | The role of DOT-Watcher 2 in Vietnam MDR-TB management
Dat Phan Thuong, MD., PhD.
Head of MDR-TB Department, Pham Ngoc Thach TB & Lung Diseases Hospital, Vietnam |
| 1000-1030 |
Tuberculosis – Complementary actions to national (VN) tuberculosis control program Van Linh Pham, MD., PhD. |
|
1030-1100
|
Coffee Break |
Section V: Idiopathic Pulmonary Fibrosis Moderator: Chi-Li Chung, MD., PhD.,
Director of Division of Pulmonary Medicine, Taipei Medical University Hospital, Taipei Medical University |
|
| 1100-1130 | IPF perspectives and challenges
Kai-Ling Lee, MD.
Division of Pulmonary Medicine, Taipei Medical University Hospital, Taipei Medical University |
| 1130-1200 | Overview of pathogenesis of IPF and emerging drug targets strategies
Kuan-Yuan Chen, MD.
Division of Pulmonary Medicine, Shuang Ho Hospital, Taipei Medical University |
| 1200-1230 | Closing Remark |
